Journal
BREAST CANCER RESEARCH
Volume 7, Issue 4, Pages 149-152Publisher
BMC
DOI: 10.1186/bcr1202
Keywords
-
Categories
Funding
- NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400] Funding Source: NIH RePORTER
- NCI NIH HHS [R01 CA092004, CA92004] Funding Source: Medline
- NCRR NIH HHS [P41 RR008079, RR08079, RR00400, M01 RR000400] Funding Source: Medline
Ask authors/readers for more resources
A technique called in vivo magnetic resonance spectroscopy (MRS) can be performed along with magnetic resonance imaging (MRI) to obtain information about the chemical content of breast lesions. This information can be used for several clinical applications, such as monitoring the response to cancer therapies and improving the accuracy of lesion diagnosis. Initial MRS studies of breast cancer show promising results, and a growing number of research groups are incorporating the technique into their breast MRI protocols. This article introduces H-1-MRS of the breast, reviews the literature, discusses current methods and technical issues, and describes applications for treatment monitoring and lesion diagnosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available